SOLV
SolventumANYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Execution on new product ramps and margin expansion plus stable end-market demand could re-rate the stock toward premium specialty-chemical multiples, supporting a >40% upside to the anchor.
Posture
Constructive
Lead driver
Momentum
What changed
1 setup hits (3d) with net bullish as of 2026-06-03.
What can break
A sustained raw-material price shock, missed commercial ramps, or weaker end-market demand could push valuation down materially; illiquidity could amplify downside.
Momentum
76
Value
57
Sentiment
56
Setup hits (3d)
1 · Net Bullish
AI TargetsBase $95.00 · Bull $120.00 · Bear $60.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-27 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Bullish
Target $91.91
Why
Momentum76 · Δ7d -2.4
Value57 · Δ7d -0.1
Sentiment56 · Δ7d +5.4
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
76
34% active weight
Current posture
7d trendImproving
Δ7d
-2.4
Δ21d
+32.6
Value
57
32% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.1
Sentiment
56
33% active weight
Current posture
7d trendImproving
Δ7d
+5.4
Δ21d
+6.2
Why this grade
Composite grade A. Momentum 76.3 / Value 56.7 / Sentiment 55.8
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$13.24B
Beta
-
Shares Out
173.45M
P/E (TTM)
9.3
P/S (TTM)
1.67
P/FCF (TTM)
280.29
Rev YoY
+0.7%
EPS YoY
+928.8%
Gross Margin
+54.2%
Op Margin
+25.1%
Net Debt
$7.25B
Current Ratio
1.50
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology